0001162044-24-000511.txt : 20240520 0001162044-24-000511.hdr.sgml : 20240520 20240520122630 ACCESSION NUMBER: 0001162044-24-000511 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240328 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 PERIOD START: 20240630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSS AMERICAFIRST QUANTITATIVE FUNDS CENTRAL INDEX KEY: 0001539996 ORGANIZATION NAME: IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-22669 FILM NUMBER: 24963132 BUSINESS ADDRESS: STREET 1: 9700 VILLAGE CENTER DRIVE STREET 2: SUITE 50-N CITY: GRANITE BAY STATE: CA ZIP: 95746 BUSINESS PHONE: 916-757-6862 MAIL ADDRESS: STREET 1: 9700 VILLAGE CENTER DRIVE STREET 2: SUITE 50-N CITY: GRANITE BAY STATE: CA ZIP: 95746 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAFIRST QUANTITATIVE FUNDS DATE OF NAME CHANGE: 20120119 0001539996 S000036988 DSS AmericaFirst Monthly Risk-On Risk-Off Fund C000113168 DSS AmericaFirst Monthly Risk-On Risk-Off Fund Class A ABRFX C000113169 DSS AmericaFirst Monthly Risk-On Risk-Off Fund Class U ABRUX C000113170 DSS AmericaFirst Monthly Risk-On Risk-Off Fund Class I ABRWX NPORT-P 1 primary_doc.xml NPORT-P false 0001539996 XXXXXXXX S000036988 C000113168 C000113169 C000113170 DSS AMERICAFIRST QUANTITATIVE FUNDS 811-22669 0001539996 549300KFIJ1ZWDPJB360 9700 Village Center Drive Suite 50-N Granite Bay 95746 916-787-9940 AmericaFirst Monthly Risk-On Risk-Off Fund S000036988 5493004NDZ0MYDSQM790 2024-06-30 2024-03-28 N 5227274.20 179169.59 5048104.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 N Adobe, Inc. FU4LY2G4933NH2E1CP29 Adobe, Inc. 00724F101 350.00 NS USD 176610.00 3.50 Long EC CORP US N 1 N N N Alcoa Corp. 549300T12EZ1F6PWWU29 Alcoa Corp. 013872106 3822.00 NS USD 129145.38 2.56 Long EC CORP US N 1 N N N Aldeyra Therapeutics, Inc N/A Aldeyra Therapeutics, Inc 01438T106 12000.00 NS USD 39240.00 0.78 Long EC CORP US N 1 N N N Alibaba Group Holding Ltd. 5493001NTNQJDH60PM02 Alibaba Group Holding Ltd. ADS 01609W102 1987.00 NS USD 143779.32 2.85 Long EC CORP KY N 1 N N N Alphabet, Inc. 5493006MHB84DD0ZWV18 Alphabet, Inc. 02079K305 369.00 NS USD 55693.17 1.10 Long EC CORP US N 1 N N N Amazon.com, Inc. ZXTILKJKG63JELOEG630 Amazon.com, Inc. 023135106 936.00 NS USD 168835.68 3.34 Long EC CORP US N 1 N N N Atomera, Inc. N/A Atomera, Inc. 04965B100 5037.00 NS USD 31027.92 0.61 Long EC CORP US N 1 N N N Broadcom, Inc. 549300WV6GIDOZJTV909 Broadcom, Inc. 11135F101 85.00 NS USD 112659.85 2.23 Long EC CORP US N 1 N N N Coherus Biosciences, Inc. 5493007IL8W5MV932D26 Coherus Biosciences, Inc. 19249H103 54805.00 NS USD 130983.95 2.59 Long EC CORP US N 1 N N N CrowdStrike Holdings, Inc. 549300YBY08K9KM4HX32 CrowdStrike Holdings, Inc. 22788C105 365.00 NS USD 117015.35 2.32 Long EC CORP US N 1 N N N DraftKings, Inc. 5493008P45UYYL683Z97 DraftKings, Inc. 26142V105 4545.00 NS USD 206388.45 4.09 Long EC CORP US N 1 N N N Eli Lilly & Co. FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co. 532457108 348.00 NS USD 270730.08 5.36 Long EC CORP US N 1 N N N Federated Hermes Institutional Prime Obligations Fund N/A Federated Prime Obligations 60934N203 522968.80 NS USD 522968.80 10.36 Long STIV RF US N 1 N N N Gritstone Bio, Inc. 5493003TER6KY3MUVY84 Gritstone Bio, Inc. 39868T105 119643.00 NS USD 307482.51 6.09 Long EC CORP US N 1 N N N International Business Machines Corp. VGRQXHF3J8VDLUA7XE92 International Business Machines Corp. 459200101 515.00 NS USD 98344.40 1.95 Long EC CORP US N 1 N N N Kyndryl Holdings, Inc. 549300LQ4LWX2R8ZV130 Kyndryl Holdings, Inc. 50155Q100 4614.00 NS USD 100400.64 1.99 Long EC CORP US N 1 N N N Meta Platforms, Inc. BQ4BKCS1HXDV9HN80Z93 Meta Platforms, Inc. Class A 30303M102 317.00 NS USD 153928.86 3.05 Long EC CORP US N 1 N N N Micron Technology, Inc. B3DXGBC8GAIYWI2Z0172 Micron Technology, Inc. 595112103 1947.00 NS USD 229531.83 4.55 Long EC CORP US N 1 N N N Microsoft Corp. INR2EJN1ERAN0W5ZP974 Microsoft Corp. 594918104 447.00 NS USD 188061.84 3.73 Long EC CORP US N 1 N N N Monte Rosa Therapeutics, Inc. N/A Monte Rosa Therapeutics, Inc. 61225M102 43715.00 NS USD 308190.75 6.10 Long EC CORP US N 1 N N N NVIDIA Corp. 549300S4KLFTLO7GSQ80 NVIDIA Corp. 67066G104 250.00 NS USD 225890.00 4.47 Long EC CORP US N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 670100205 2000.00 NS USD 256800.00 5.09 Long EC CORP DK N 1 N N N Nu Holdings Ltd. 5493002DG1RHWK9W2X27 Nu Holdings Ltd. G6683N103 25551.00 NS USD 304823.43 6.04 Long EC CORP KY N 1 N N N Omega Therapeutics, Inc. N/A Omega Therapeutics, Inc. 68217N105 43045.00 NS USD 157114.25 3.11 Long EC CORP US N 1 N N N Oracle Corp. 1Z4GXXU7ZHVWFCD8TV52 Oracle Corp. 68389X105 1380.00 NS USD 173341.80 3.43 Long EC CORP US N 1 N N N Palantir Technologies, Inc. 549300UVN46B3BBDHO85 Palantir Technologies, Inc. 69608A108 4257.00 NS USD 97953.57 1.94 Long EC CORP US N 1 N N N RTX Corp. I07WOS4YJ0N7YRFE7309 RTX Corp. 75513E101 598.00 NS USD 58322.94 1.16 Long EC CORP US N 1 N N N Reddit, Inc. N/A Reddit, Inc. 75734B100 1735.00 NS USD 85570.20 1.69 Long EC CORP US N 1 N N N TG Therapeutics, Inc. 529900X21UKABN9NJ529 TG Therapeutics, Inc. 88322Q108 20845.00 NS USD 317052.45 6.28 Long EC CORP US N 1 N N N 2024-03-28 AmericaFirst Quantitative Funds /s/ Rick Gonsalves Rick Gonsalves Trustee and President XXXX NPORT-EX 2 dssamericafirstriskonoff.htm NPORT-EX




Schedule of Investments

March 31, 2024 (unaudited)

AmericaFirst Risk-On Risk-Off Fund

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares or Principal

 

 

Security Description

 

 

Amount ($)

 

Fair Value ($)(1)

 

 

 

 

 

 

Common Stocks - 92.01%

 

 

 

 

 

 

 

 

Aerospace and Defense - 1.16%

 

 

 

 

 

RTX Corp.

 

 

 

 

598

 

58,323

 

 

 

 

 

 

 

 

Aluminum - 2.56%

 

 

 

 

 

 

Alcoa Corp.

 

 

 

 

3,822

 

129,145

 

 

 

 

 

 

 

 

Banks - 6.04%

 

 

 

 

 

 

Nu Holdings Ltd. (2)

 

 

 

25,551

 

304,823

 

 

 

 

 

 

 

 

Biological Products - 2.59%

 

 

 

 

 

Coherus BioSciences, Inc.

 

 

54,805

 

130,984

 

 

 

 

 

 

 

 

Biotechnology - 22.37%

 

 

 

 

 

Aldeyra Therapeutics, Inc.

 

 

12,000

 

39,240

Gritstone Bio, Inc.

 

 

 

119,643

 

307,483

Monte Rosa Therapeutics, Inc.

 

 

43,715

 

308,191

Omega Therapeutics, Inc.

 

 

 

43,045

 

157,114

TG Therapeutics, Inc.

 

 

 

20,845

 

317,052

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,129,080

 

 

 

 

 

 

 

 

Gambling - 4.09%

 

 

 

 

 

 

DraftKings, Inc.

 

 

 

4,545

 

206,388

 

 

 

 

 

 

 

 

IT Services - 1.95%

 

 

 

 

 

 

International Business Machines Corp.

 

 

515

 

98,344

 

 

 

 

 

 

 

 

Interactive Media Services - 4.15%

 

 

 

 

 

Alphabet, Inc. Class A

 

 

 

369

 

55,693

Meta Platforms Inc. Class A

 

 

317

 

153,929

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

209,622

 

 

 

 

 

 

 

 

Internet Content & Information  - 1.70%

 

 

 

 

 

Reddit, Inc.

 

 

 

 

1,735

 

85,570

 

 

 

 

 

 

 

 

Internet Retail  - 2.85%

 

 

 

 

 

 

Alibaba Group Holding Ltd. ADS

 

 

1,987

 

143,779

 

 

 

 

 

 

 

 

Pharmaceuticals - 10.45%

 

 

 

 

 

Eli Lilly & Co.

 

 

 

348

 

270,730

Novo Nordisk A/S

 

 

 

2,000

 

256,800

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

527,530

 

 

 

 

 

 

 

 

Retail Catalog & Mail-Order Houses - 3.34%

 

 

 

 

 

Amazon.com, Inc. (2)

 

 

 

936

 

168,836

 

 

 

 

 

 

 

 

Semiconductors - 4.47%

 

 

 

 

 

NVIDIA Corp.

 

 

 

250

 

225,890

 

 

 

 

 

 

 

 

Semiconductors & Related Devices - 7.39%

 

 

 

 

 

Atomera, Inc.

 

 

 

 

5,037

 

31,028

Broadcom, Inc.

 

 

 

85

 

112,660

Micron Technology, Inc.

 

 

 

1,947

 

229,532

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

373,220

 

 

 

 

 

 

 

 

Services-Computer Processing & Data Preparation - 1.99%

 

 

 

 

 

Kyndryl Holdings, Inc.

 

 

 

4,614

 

100,401

 

 

 

 

 

 

 

 

Services-Prepackaged Software - 3.50%

 

 

 

 

 

Adobe, Inc. (2)

 

 

 

350

 

176,610

 

 

 

 

 

 

 

 

Software- 11.42%

 

 

 

 

 

 

CrowdStrike Holdings, Inc.

 

 

365

 

117,015

Microsoft Corp.

 

 

 

447

 

188,062

Oracle Corp.

 

 

 

 

1,380

 

173,342

Palantir Technologies, Inc.

 

 

4,257

 

97,954

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

576,373

 

 

 

 

 

 

 

 

Total Common Stock

 

 

 

(Cost $           3,850,597)

 

4,644,918

 

 

 

 

 

 

 

 

Money Market Registered Companies - 10.36%

 

 

 

 

Federated Hermes Institutional Prime Obligations Fund - Institutional Class, 5.37% (4)

 

522,969

 

522,969

 

 

 

 

 

 

 

 

Total Money Market Registered Investment Companies

 

 

(Cost $              522,969)

 

522,969

 

 

 

 

 

 

 

 

Total Investments - 102.37%

(Cost $           4,305,771)

 

5,167,887

 

 

 

 

Liabilities in Excess of Other Assets - -2.37%

 

 

(119,782)

 

 

 

 

Total Net Assets - 100.00%

 

 

5,048,105

 

 

 

 

 

 

 

 

 

 

 

 

(1)  Statement on Financial Accounting Standard No. 157 "Fair Value Measurements" - Various inputs are used in determining the value of the Fund's investments.

       These inputs are summarized in the three broad levels listed below.

        • Level 1 - quoted prices in active markets for identical securities

        • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)

        • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments)

 

       The following is a summary of the inputs used as of March 28, 2024 in valuing the Fund's assets carried at fair value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in

 

Other Financial

Valuation Inputs

 

 

 

Securities

 

Instruments (9)

Level 1 - Quoted Prices

 

 

$

5,167,887

$

0

Level 2 - Other Significant Observable Inputs

 

$

0

$

0

Level 3 - Significant Unobservable Inputs

 

$

0

$

0

Total

 

 

 

$

5,167,887

$

0

 

 

 

 

 

 

 

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term

debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment

Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active

market, such securities are reflected as Level 2.

 

 

 

 

 

 

 

 

(2)   Represents non-income producing securities.

(4)  Variable rate security; the rate shown represents the yield at March 28, 2024.